» Articles » PMID: 18565732

Pregnancy Outcomes in Women with Epilepsy: a Systematic Review and Meta-analysis of Published Pregnancy Registries and Cohorts

Overview
Journal Epilepsy Res
Specialty Neurology
Date 2008 Jun 21
PMID 18565732
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To conduct a systematic review and meta-analysis to quantify the incidence of congenital malformations (CMs) and other pregnancy outcomes as a function of in utero anti-epileptic drug (AED) exposure.

Methods: We performed a systematic literature review to identify all published registries and cohort studies of births from pregnant women with epilepsy (WWE) that reported incidence of CMs. Overall incidences were calculated using a random effects model.

Results: The review included 59 studies that met inclusion/exclusion criteria, involving 65,533 pregnancies in WWE and 1,817,024 in healthy women. The calculated incidence of births with CM in WWE [7.08%; 95% CIs 5.62, 8.54] was higher than healthy women [2.28%; CIs 1.46, 3.10]. Incidence was highest for AED polytherapy [16.78%; CIs 0.51, 33.05]. The AED with the highest CM incidence was valproate, which was 10.73% [CIs 8.16, 13.29] for valproate monotherapy.

Conclusions: Results of this systematic literature review suggest that the overall incidence of CMs in children born of WWE is approximately threefold that of healthy women. The risk is elevated for all AED monotherapy and further elevated for AED polytherapy compared to women without epilepsy. The risk was significantly higher for children exposed to valproate monotherapy and to polytherapy of 2 or more drugs when the polytherapy combination included phenobarital, phenytoin, or valproate. Further research is needed to delineate the specific risk for each individual AED and to determine underlying mechanisms including genetic risk factors.

Citing Articles

The use of newer anti-seizure medicines in women with epilepsy in pregnancy: A case series.

Devin J, OShaughnessy F, Sardana M, Cleary B, Donnelly J, Maher N Epilepsy Behav Rep. 2025; 29:100741.

PMID: 39927179 PMC: 11804773. DOI: 10.1016/j.ebr.2025.100741.


Epilepsy and Anti-Seizure Medications: Secret Agents for Endocrine Disruption.

Sazgar M, Mnatsakanyan L, Pack A, Harden C Epilepsy Curr. 2024; 24(2):79-83.

PMID: 39280049 PMC: 11394407. DOI: 10.1177/15357597231213248.


Morbidity and mortality risks associated with valproate withdrawal in young adults with epilepsy.

Mbizvo G, Bucci T, Lip G, Marson A Brain. 2024; 147(10):3426-3441.

PMID: 38657115 PMC: 11449131. DOI: 10.1093/brain/awae128.


Issues of Women with Epilepsy and Suitable Antiseizure Drugs.

Lee S J Epilepsy Res. 2024; 13(2):23-35.

PMID: 38223363 PMC: 10783964. DOI: 10.14581/jer.23005.


Evidence from Finland and Sweden on the relationship between early-life diseases and lifetime childlessness in men and women.

Liu A, Akimova E, Ding X, Jukarainen S, Vartiainen P, Kiiskinen T Nat Hum Behav. 2023; 8(2):276-287.

PMID: 38110509 PMC: 10896715. DOI: 10.1038/s41562-023-01763-x.


References
1.
German J, Kowal A, Ehlers K . Trimethadione and human teratogenesis. Teratology. 1970; 3(4):349-62. DOI: 10.1002/tera.1420030412. View

2.
Shakir R, Abdulwahab B . Congenital malformations before and after the onset of maternal epilepsy. Acta Neurol Scand. 1991; 84(2):153-6. DOI: 10.1111/j.1600-0404.1991.tb04924.x. View

3.
Knight A, RHIND E . Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia. 1975; 16(1):99-110. DOI: 10.1111/j.1528-1157.1975.tb04726.x. View

4.
MUELLER-KUEPPERS M . [ON THE PROBLEM OF FETAL DAMAGE DURING PREGNANCY CAUSED BY INTAKE OF ANTICONVULSANTS]. Acta Paedopsychiatr. 1963; 30:401-5. View

5.
Sonneveld S, Correy J . Outcome of pregnancies complicated by epilepsy in Tasmania 1981-1988. Aust N Z J Obstet Gynaecol. 1990; 30(4):286-9. DOI: 10.1111/j.1479-828x.1990.tb02012.x. View